Staxyn
Product Images NDC 54868-6333

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Staxyn (NDC 54868-6333). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (0e5139d8 Bf61 4f21 A36b 81b96b9b07d1 01)

Chemical structure diagram of the active ingredient in Staxyn, showing the detailed molecular arrangement including functional groups and hydration state with hydrochloride and trihydrate components.*

FDA Label Image

Figure 1 (0e5139d8 Bf61 4f21 A36b 81b96b9b07d1 02)

This chart presents three plots showing mean maximal changes in systolic blood pressure, diastolic blood pressure (in mmHg), and heart rate (in bpm) over time following Vardenafil treatment pre-NTG. The x-axis indicates time points from -24 hours to 1 hour, with error bars representing variability for each measurement.*

FDA Label Image

Figure 2 (0e5139d8 Bf61 4f21 A36b 81b96b9b07d1 03)

A line graph showing the mean change in mmHg over time (hours) for four groups: Placebo (Simultaneous), Placebo (5 Hr Separation), Vardenafil 5 mg (Simultaneous), and Vardenafil 5 mg (5 Hr Separation). The y-axis represents mean change in mmHg, and the x-axis represents time in hours, illustrating the blood pressure response over a 6-hour period.*

FDA Label Image

Figure 3 (0e5139d8 Bf61 4f21 A36b 81b96b9b07d1 04)

A line graph showing the mean change in mmHg over time (hours) for placebo and vardenafil 5 mg, each with simultaneous and separated dosing conditions. The x-axis represents time from 0 to 6 hours, and the y-axis shows mean change in mmHg ranging from -15 to 15.*

FDA Label Image

Figure 4 (0e5139d8 Bf61 4f21 A36b 81b96b9b07d1 05)

A line graph showing the mean change in mmHg over time (hours) for Staxyn at doses of 10 mg and 20 mg compared to placebo in two stages. The graph illustrates blood pressure changes with a downward trend for Vardenafil (Staxyn) doses over a 6-hour period, while placebo lines fluctuate around zero.*

FDA Label Image

Figure 5 (0e5139d8 Bf61 4f21 A36b 81b96b9b07d1 06)

A line graph titled 'TERAZOSIN' showing mean change in mmHg on the y-axis and time in hours on the x-axis. The graph compares placebo and two doses of Vardenafil (10 mg and 20 mg) under two conditions: 6-hour separation and simultaneous administration, depicting their effects over a 6-hour period.*

FDA Label Image

Figure 6 (0e5139d8 Bf61 4f21 A36b 81b96b9b07d1 07)

A line graph titled 'TAMSULOSIN' showing mean change (mmHg) on the vertical axis and time (hours) on the horizontal axis. It compares the effects of placebo and varedenafil at 10 mg and 20 mg dosages under two conditions: 6-hour separation and simultaneous administration. Multiple lines with different markers depict changes over a 6-hour period.*

FDA Label Image

Figure 7 (0e5139d8 Bf61 4f21 A36b 81b96b9b07d1 08)

A line graph depicting plasma concentration (µg/L) over time (hours). The graph shows a peak plasma concentration around 1 hour after dosing, followed by a gradual decline over 15 hours, with error bars indicating variability at each time point.*

FDA Label Image

Staxyn 4 Tablet Package Label (6333)

Packaging label for Staxyn 10 mg tablets, distributed by Physicians Total Care, Inc. The label shows the product NDC 54868-6333, contains 4 tablets, and includes lot number 0000 with an expiration date of 01/66. A barcode is located at the bottom of the label.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.